Literature DB >> 28534347

Recent perspectives of management of breast cancer metastasis - an update.

Qingzhong Tian1, Yun Wang, Hao Guo, Guangwei Xie, Jin Li, Minkang Zhang, Qianjin Zhang, Qingliang Meng.   

Abstract

Breast cancer is the leading cause of cancer related deaths in women and one of the most common cancers globally. The major obstacle in the management of breast cancer, especially at advanced stages, is metastasis. Metastasis in the advanced stages of breast cancer could decrease survival to approximately 5 years. The reasons could include lack of targeted receptors or chemotherapeutic agents for the management of advanced-stage breast cancer metastasis. The new emerging avenues for the management of this deadly pathological state include local manipulations like radiofrequency ablation (RFA), microwave thermotherapy, cryosurgery (cryotherapy), chemoembolization, radioembolization, breast surgery, or metastasectomy. Few single-institution reports showed improved survival in selected patients like those with oligometastatic stage IV breast cancer. The present review article focused on these emerging new multimodality treatment approaches for a possible efficient management.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534347

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

Review 1.  Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.

Authors:  Ian C Harding; Ronodeep Mitra; Solomon A Mensah; Alina Nersesyan; Nandita N Bal; Eno E Ebong
Journal:  Biorheology       Date:  2019       Impact factor: 1.875

Review 2.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  Metastatic cancer cell attachment to endothelium is promoted by endothelial glycocalyx sialic acid degradation.

Authors:  Solomon A Mensah; Ian C Harding; Michelle Zhang; Michael P Jaeggli; Vladimir P Torchilin; Mark J Niedre; Eno E Ebong
Journal:  AIChE J       Date:  2019-05-09       Impact factor: 3.993

4.  Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.

Authors:  Ganiou Assani; Julien Segbo; Xiaoyan Yu; Akadiri Yessoufou; Yudi Xiong; Fuxiang Zhou; Yunfeng Zhou
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

5.  A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer.

Authors:  Manqiang Sun; Tian Zhou; Xueni Fang; Dan Wang; Haoyue Pang; Yu Chen; Kaiwen Hu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.